IMV receives funding for trials of its Covid-19 vaccine candidate
DPX-Covid-19 is a slightly different vaccine approach compared to traditional approach. Credit: Jernej Furman.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more